19 October 2020 - Deborah Wilkes
Premium
Teva’s Desloratadine ratiopharm is set to become the sixth medicine to gain non-prescription status through the European Union’s centralised authorisation procedure.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.